AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letragic 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Neorangic Healthcare Private Limited

Salt Composition

Letrozole (2.5mg)

Overview Letragic 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letragic 2.5mg Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. For individuals with advanced breast cancer, it aids in preventing metastasis. Letragic 2.5mg Tablets can be ingested with or without food, always adhering to your physician's prescribed dosage and duration for optimal efficacy. Dosage frequency varies depending on the treatment goal, determined by your doctor to manage your symptoms effectively. Continuous use, as directed, is crucial. Common side effects include excessive sweating, tiredness, hot flashes, and elevated cholesterol. Report any concerning or persistent side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or current medications, as interactions may occur. Disclose any pregnancy or breastfeeding to your physician. Pre- and ongoing monitoring of vitamin D levels and bone density through blood tests may be implemented.

Primary Ingredients of Letragic 2.5mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Letragic 2.5mg Tablet

Managing breast cancer

Major Benefits of Letragic 2.5mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Letragic 2.5mg Tablets. Swallow the tablet whole; do not chew, crush, or divide it. While you can take it with or without food, consistency is key—take it at the same time each day.

Common Side effects of Letragic 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letragic 2.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Letragic 2.5mg Tablets. Ingest the tablets whole; do not chew, crush, or fracture them. These tablets can be taken with or without food, although consistent timing is recommended.

How Letragic 2.5mg Tablet works:

Estrogen production is reduced by Letragic 2.5mg Tablets, an aromatase inhibitor. This reduction in estrogen levels can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Ingesting alcohol alongside Letragic 2.5mg tablets presents no known adverse reactions.

PregnancyPregnancyUNSAFE

Using Letragic 2.5mg tablets during pregnancy poses a serious risk. Pregnant women should consult their physician; research in both animals and pregnant humans indicates substantial harm to the fetus.

Breast feedingBreast feedingUNSAFE

Lactational use of Letragic 2.5mg tablets is contraindicated due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, or dizziness after taking Letragic 2.5mg tablets, as these symptoms may impair alertness.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, the 2.5mg Letragic tablet is considered safe, and no dosage alteration is necessary. Data regarding its use in patients with end-stage renal failure, however, is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Letragic 2.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letragic 2.5mg Tablet :

Should you forget a Letragic 2.5mg Tablet dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letragic 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letragic 2.5mg Tablet

Letragic 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letragic 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen. Since estrogen fuels the growth of certain breast cancers—those termed "estrogen-dependent cancers"—reducing estrogen levels can help prevent cancer progression.
For advanced breast cancer or cancer that has spread, continue Letragic 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letragic 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letragic 2.5mg Tablet followed by three years of tamoxifen may be used.
It's safe to combine irbesartan with Letragic 2.5mg, but monitor your blood pressure closely as Letragic 2.5mg can elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letragic 2.5mg Tablets may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Experiencing hot flushes may indicate a common side effect of Letragic 2.5mg Tablet, linked to reduced estrogen. These usually lessen as your body adapts, but may persist throughout treatment and subside afterward. If bothersome, consult your doctor for management options.
Letragic 2.5mg Tablet may cause serious side effects, such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions, though these are rare.
Letragic 2.5mg Tablets can reduce bone density (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Letragic 2.5mg Tablets to inducing ovulation in women with anovulatory infertility.
Letragic 2.5mg Tablet
21